Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,347,748
-$178,939 QoQ
Shares Held
190,360
0.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#40
of 164 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital International, Inc./CA/ holds $998,315,428 across 11 Drug Manufacturers - General names. GRFS ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,949,177 | $369,602,942 | |
| 2 | LLY |
ELI LILLY & Co
|
198,681 | $238,303,971 | |
| 3 | ABBV |
AbbVie Inc.
|
435,569 | $109,606,583 | |
| 4 | AMGN |
Amgen Inc
|
299,765 | $108,550,901 | |
| 5 | MRK |
Merck & Co., Inc.
|
454,397 | $58,390,014 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
363,947 | $45,981,063 | |
| 7 | JNJ |
Johnson & Johnson
|
178,793 | $45,408,058 | |
| 8 | PFE |
Pfizer Inc
|
376,556 | $9,067,468 |
All Filings in GRFS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,347,748 | 190,360 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,526,687 | 190,360 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,779,866 | 190,360 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,946,184 | 195,400 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,766,416 | 195,400 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,374,860 | 193,370 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,390,044 | 186,834 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,736,670 | 195,571 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,243,877 | 197,128 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,340,655 | 200,697 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,320,300 | 200,718 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,674,557 | 183,212 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,502,111 | 163,986 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,200,322 | 162,866 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,368,984 | 161,057 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $938,451 | 152,346 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,550,754 | 214,710 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,551,133 | 218,419 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $3,457,031 | 307,839 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,497,527 | 307,839 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,855,902 | 337,516 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,954,105 | 344,367 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,613,265 | 304,407 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,344,440 | 250,400 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||